Approval · Notice of Compliance 4659 · 1996
LEUKINE: Notice of Compliance 4659
Issued May 3, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4659
- Date
- May 3, 1996
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Hematopoietic growth factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEUKINE | 02218267 | — |
| LEUKINE | 02218275 | — |
Medicinal ingredients
- SARGRAMOSTIM 250 MCG per VIAL
- SARGRAMOSTIM 500 MCG per VIAL